Cabotegravir (USAN and INN) (also known as S/GSK1265744 or GSK744) is an investigational new drug under development for the treatment of HIV infection. It is an integrase inhibitor, with a carbamoyl pyridone structure similar to dolutegravir. In investigational studies, the agent has been packaged into nanoparticles (GSK744LAP) conferring an exceptionally long half-life of 21–50 days following a single dose. In theory, this would make possible suppression of HIV with dosing as infrequently as once every three months.
- ProName: GSK744
- CasNo:1051375-10-0
- Molecular Formula: C18H25N3O2
- Appearance: white powder
- Application: API
- DeliveryTime: 5-7 days
- PackAge: aluminous bag
- Port: shanghai
- ProductionCapacity: 10000 Kilogram/Day
- Purity: 99%
- Storage: Shading, sealed, dry place.
- Transportation: sea or air
- LimitNum: 1 Gram
- Moisture Content: 0.25%
- Impurity: 0.30%
No comments:
Post a Comment